Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with both terms appearing during the transition.
    Difference
    0.2%
    Check dated 2026-10-25T16:25:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The website’s footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.0%
    Check dated 2026-10-18T22:09:07.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-11T22:23:20.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The revision history now shows a new revision entry for v3.7.0 and removes the previous v3.6.6, reflecting an update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-09-20T22:35:22.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    History now shows a new entry Revision: v3.6.6. The previous entry Revision: v3.6.5 has been removed.
    Difference
    0.0%
    Check dated 2026-08-30T21:53:35.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a deployment of the latest platform version. No study data or history entries were modified.
    Difference
    0.0%
    Check dated 2026-08-09T09:20:38.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.